Literature DB >> 15845478

Role of interleukin-6 in mortality from and physiologic response to sepsis.

Daniel G Remick1, Gerald Bolgos, Shannon Copeland, Javed Siddiqui.   

Abstract

Previous studies have suggested that interleukin-6 (IL-6) serves as both a marker and a mediator for the severity of sepsis. We tested whether interleukin 6 knockout (IL-6KO) mice were more susceptible to sepsis mortality induced by cecal ligation and puncture. IL-6KO and wild-type (WT) mice were subjected to increasing degrees of sepsis severity. Physiologic support was given with fluids and appropriate antibiotics. Plasma IL-6 levels were determined 6 h after the onset of sepsis, and a complete hematologic profile was performed on day 2. As expected, increasing sepsis severity resulted in greater and more rapid mortality. However, the mortality was nearly identical in the IL-6KO and WT mice. All WT septic mice had high plasma levels of IL-6 6 h after the onset of sepsis, while IL-6KO were near or below the lower limit of detection. Among the WT mice, mortality was significantly higher in mice with plasma IL-6 >3,000 pg/ml. Both IL-6KO and WT mice destined to die in the early stages of sepsis had substantial and nearly identical weight gain in the first 24 h. However, at later stages the WT mice had significantly greater weight loss than the KO mice. The KO mice failed to develop the characteristic hypothermia within the first 24 h of severe sepsis routinely observed in the WT mice. These data demonstrate that IL-6 serves as a marker of disease severity in sepsis and does modulate some physiologic responses, but complete lack of IL-6 does not does not alter mortality due to sepsis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845478      PMCID: PMC1087378          DOI: 10.1128/IAI.73.5.2751-2757.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

2.  Clinical application of maternal serum cytokine determination in premature rupture of membranes--interleukin-6, an early predictor of neonatal infection?

Authors:  K A Pfeiffer; J Reinsberg; A Rahmun; J Schmolling; D Krebs
Journal:  Acta Obstet Gynecol Scand       Date:  1999-10       Impact factor: 3.636

3.  Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.

Authors:  E S de Bont; E Vellenga; J C Swaanenburg; V Fidler; P J Visser-van Brummen; W A Kamps
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

4.  Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality.

Authors:  D G Remick; D R Call; S J Ebong; D E Newcomb; P Nybom; J A Nemzek; G E Bolgos
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

5.  Compensatory hepatic regeneration after mild, but not fulminant, intraperitoneal sepsis in rats.

Authors:  Y G Weiss; L Bellin; P K Kim; K M Andrejko; C A Haaxma; N Raj; E E Furth; C S Deutschman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-05       Impact factor: 4.052

6.  Immunopathologic alterations in murine models of sepsis of increasing severity.

Authors:  S Ebong; D Call; J Nemzek; G Bolgos; D Newcomb; D Remick
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

7.  Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity.

Authors:  D Newcomb; G Bolgos; L Green; D G Remick
Journal:  Shock       Date:  1998-08       Impact factor: 3.454

8.  IL-6 is essential in TNF-alpha-induced fever.

Authors:  A K Sundgren-Andersson; P Ostlund; T Bartfai
Journal:  Am J Physiol       Date:  1998-12

9.  Intrahepatic STAT-3 activation and acute phase gene expression predict outcome after CLP sepsis in the rat.

Authors:  K M Andrejko; J Chen; C S Deutschman
Journal:  Am J Physiol       Date:  1998-12

10.  IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice.

Authors:  W Kozak; M J Kluger; D Soszynski; C A Conn; K Rudolph; L R Leon; H Zheng
Journal:  Ann N Y Acad Sci       Date:  1998-09-29       Impact factor: 5.691

View more
  83 in total

1.  Use of blood urea nitrogen, creatinine, interleukin-6, granulocyte-macrophage colony stimulating factor in combination to predict the severity and outcome of abdominal sepsis in rats.

Authors:  Min Gao; Lingli Zhang; Ying Liu; Mingshi Yang; Nian Wang; Kangkai Wang; Danmin Ou; Meidong Liu; Guangwen Chen; Ke Liu; Xianzhong Xiao
Journal:  Inflamm Res       Date:  2012-05-29       Impact factor: 4.575

Review 2.  Differential Paradigms in Animal Models of Sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

3.  Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis.

Authors:  Marcin F Osuchowski; Judith Connett; Kathleen Welch; Jill Granger; Daniel G Remick
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

4.  Hypothermia increases interleukin-6 and interleukin-10 in juvenile endotoxemic mice.

Authors:  Corrine R Stewart; Jessica P Landseadel; Matthew J Gurka; Karen D Fairchild
Journal:  Pediatr Crit Care Med       Date:  2010-01       Impact factor: 3.624

5.  Blockade of CD137 signaling counteracts polymicrobial sepsis induced by cecal ligation and puncture.

Authors:  Quang-Tam Nguyen; Seong-A Ju; Sang-Min Park; Sang-Chul Lee; Hideo Yagita; In Hee Lee; Byung-Sam Kim
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

6.  Leukocyte function-associated antigen-1 deficiency impairs responses to polymicrobial sepsis.

Authors:  Jia-Ren Liu; Xiaohui Han; Sulpicio G Soriano; Koichi Yuki
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

7.  Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2.

Authors:  Joao Incio; Jennifer A Ligibel; Daniel T McManus; Priya Suboj; Keehoon Jung; Kosuke Kawaguchi; Matthias Pinter; Suboj Babykutty; Shan M Chin; Trupti D Vardam; Yuhui Huang; Nuh N Rahbari; Sylvie Roberge; Dannie Wang; Igor L Gomes-Santos; Stefan B Puchner; Christopher L Schlett; Udo Hoffmman; Marek Ancukiewicz; Sara M Tolaney; Ian E Krop; Dan G Duda; Yves Boucher; Dai Fukumura; Rakesh K Jain
Journal:  Sci Transl Med       Date:  2018-03-14       Impact factor: 17.956

8.  Novel role for aldose reductase in mediating acute inflammatory responses in the lung.

Authors:  Thyyar M Ravindranath; Phyllus Y Mong; Radha Ananthakrishnan; Qing Li; Nosirudeen Quadri; Ann Marie Schmidt; Ravichandran Ramasamy; Qin Wang
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  Caecal ligation and puncture in the rat mimics the pathophysiological changes in human sepsis and causes multi-organ dysfunction.

Authors:  H F Brooks; C K Osabutey; R F Moss; P L R Andrews; D C Davies
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

10.  Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain.

Authors:  Eléonore Beurel; Richard S Jope
Journal:  J Neuroinflammation       Date:  2009-03-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.